Stock ATTBF ABATTIS BIOCEUTICALS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Abattis Bioceuticals Corp.

Equities

ATTBF

CA00258G1037

Market Closed - OTC Markets
Other stock markets
 12:15:14 2024-07-02 pm EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Abattis Bioceuticals Corp. 0.00% 0.00%
2020 Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019 CI
2019 Abattis Bioceuticals Corp. Announces Board Changes CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019
CI
Abattis Bioceuticals Corp. Announces Board Changes
CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of NutriVida Corp.
CI
Abattis Bioceuticals Corp. Reports Earnings Results for the Third Quarter Ended June 30, 2019
CI
Abattis Bioceuticals Corp.'s Equity Buyback announced on August 7, 2018, has expired.
CI
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2018
CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of Winston Resources Inc..
CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) completed the acquisition of Pro Natura BV from The Catalyst Capital Group Inc.
CI
Abattis Bioceuticals : Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
PR
Abattis Bioceuticals Corp. Announces Management Changes
CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) agreed to acquire Pro Natura BV from The Catalyst Capital Group Inc. for €15.7 million.
CI
Abattis Bioceuticals Corp. Announces Resignations in Board
CI
British Columbia Securities Commission Removes Temporary Order on Abattis Bioceuticals Corp
CI
Abattis Bioceuticals Corp Announces Launch of Its New Website and Provide an Operational Update
CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) signed a letter of intent to acquire NutriVida Corp. for CAD 15 million.
CI
Abattis Bioceuticals Corp Signs a Distribution Agreement with Shefield &Sons Tobacconists Inc. to Sell the Abattis Vaporizer Line in all Shefield &Sons Stores Across Canada
CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) acquired Select Strains Inc. for $3.5 million.
CI
Abattis Bioceuticals Corp. Announces Executive Changes
CI
Abattis Intends To Seek Acquisitions
CI
Abattis Bioceuticals Corp. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATTBF Stock
  4. News Abattis Bioceuticals Corp.